Navigation Links
NMP22® BladderChek® Kit (1-test kit)

ProductsNMP22® BladderChek® Kit (1-test kit)
Company Matritech, Inc.
Item NMP22® BladderChek® Kit (1-test kit)
Features 
  • Negative Predictive Value of >86%.
  • Within-run CVs are <6% in patient samples.
  • Total CVs are <10%.
  • The linearity of specimen dilution demonstrates a correlation coefficientof>0.993 with a mean recovery of 99%.
  • Unlike other tests, NMP22 values are not affected by gross hematuria and common intravesical treatments such as BCG or thiotepa.
  • The dual monoclonal antibody assay is supplied in microwell format.
  • Results are read on a microplate reader at 490 nm.
Description The NMP22® Test Kit is a quantitative microplate enzyme immunoassay that can identify bladder cancer patients who are at risk for rapid recurrence or occult disease. The test is performed on a single voided urine sample and is twice as sensitive as urine cytology. Urologists can use NMP22 values to improve patient outcome by identifying those patients who may benefit from more or less aggressive management. NMP22 is a Nuclear Matrix Protein found in human epithelial cells. In the urine of healthy individuals, the protein is present at low levels. The majority of patients with bladder cancer release large quantities of NMP22 into their urine.
Info Matritech, Inc.
Customer Service: (617) 928-0820

Related medicine products :

1. NMP22® BladderChek® Kit (24-test kit)
2. NMP22® Test Kit
The screening test for colorectal cancer that's simple, convenient, and effective....
A rapid, convenient, qualitative method for detecting asymptomatic occult bleeding....
... 500,000 people die each year of ... Despite diagnostic improvements (high contrast berium ... an increase in the success rate ... has not been achieved over the ...
... of guaiac as a test for the presence ... phenolic compounds present in guaiac to quinones, resulting ... blood is present, the heme portion of the ... catalyzing the release of oxygen from hydrogen peroxide ...
Medicine Products:
(Date:5/26/2016)... ... 2016 , ... There are nearly 14.5 million people living with and beyond ... Sunday, June 5, 2016, communities around the world will gather to recognize these cancer ... Cancer Survivors Day® is an annual worldwide Celebration of Life that is held on ...
(Date:5/26/2016)... N.J. (PRWEB) , ... May 26, 2016 , ... ... delivery technologies and development solutions for drugs, biologics, consumer health and global clinical ... sales office in Korea to support the company’s continued investment and strategic growth ...
(Date:5/26/2016)... ... 2016 , ... An April Gallup survey found rising health care costs to ... Sun Health Senior Living (SHSL) may not share those same worries thanks to ... for the year, while holding the line on increasing their contributions, including premiums, deductibles ...
(Date:5/26/2016)... ... May 26, 2016 , ... Memorial Day Weekend marks the unofficial start ... is sharing tips to make sure your family and vehicle are ready to hit ... there may be 439 deaths and an additional 50,500 serious injuries from motor vehicle ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... provider of comprehensive treatment for eating disorders, is opening a brand new child ... provide individuals ages 8-17 and their families with even more specialized eating disorder ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
(Date:5/25/2016)... -- FDA 510(k) clearance covers Confocal ... urological and surgical applications Mauna Kea ... the multidisciplinary confocal laser endomicroscopy (CLE) platform, today ... with the 12 th 510(k) clearance from ... new FDA clearance covers Confocal Miniprobes indicated for ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, 2016 ... ; Frankfurt Prime Standard: QIA) today announced that the company ... Diagnostics GmbH to develop and commercialize predictive assays in oncology. ... as a marker to predict effectiveness of anthracycline treatment in ... "We are pleased to partner with Therawis, which developed the ...
Breaking Medicine Technology: